The mutations of TP53 gene were a negative prognostic factor for overall survival (OS) of advanced non‐small‐cell lung cancer (NSCLC) patients, and, in EGFR‐mutated patients, additional mutations of TP53 gene were associated with shorter OS [28]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.